Clinical trials
Terminated Urinary Bladder Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 1 |
| Bioniche Life Sciences Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Eisai Inc. | 1 |
| Eli Lilly and Company | 1 |
| European Association of Urology Research Foundation | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |
| Photocure | 1 |
| Rainier Therapeutics | 1 |
| WiSP Wissenschaftlicher Service Pharma GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 11 |
| Carcinoma, Transitional Cell | 4 |
| Carcinoma in Situ | 2 |
| Urinary Bladder Diseases | 2 |
| Urologic Diseases | 2 |
| Immune System Diseases | 1 |
| Lymphoproliferative Disorders | 1 |
| Mycobacterium Infections | 1 |
| Neoplasm Recurrence, Local | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.